Literature DB >> 16118516

[Current status of liver transplantation in Korea].

Sung Gyu Lee1.   

Abstract

Orthotopic liver transplantation (OLT) is now considered as a standard procedure for patients with end-stage liver disease. The number of patients listed for OLT using the brain-dead donor continues to outpace the number of OLT performed since early 1990s because the improved results of OLT had made it as a therapeutic means for irreversible liver disease. This scarcity of organs from the deceased donors has resulted in the increased use of the living donor liver grafts. Although the shortage of the brain-dead donor organs is a world-wide problem, the situation is especially serious in our country, where the deceased donor organ donation remains below 2 per million population per year. Now, Korea has the greatest need for living donor liver transplantation although it is more complex and demanding procedure than the deceased donor (whole organ) liver transplantation. Refinements of the technique and good results have rapidly established the position of the living donor liver transplantation in our country's transplant medicine. 2,345 OLTs (1,860 from the living donor and 485 from the deceased donor) were performed in 24 institutes from March 1988 to December 2004, although 5 institutes had performed more than 10 OLTs per year. Definitely, living donors represent a large pool of organs, but there might be a significant cost, mainly donor risk, to draw from this pool. To alleviate some disadvantages of the living donor liver transplantation and to provide organ to the patients who cannot find out the potential living donor from family members, recognition of necessity and nation-wide cooperative participation of organ donation after the brain-death should be propagated and encouraged in our country.

Entities:  

Mesh:

Year:  2005        PMID: 16118516

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  2 in total

1.  Risk factors of intra-abdominal bacterial infection after liver transplantation in patients with hepatocellular carcinoma.

Authors:  Kai Nie; Rongzheng Ran; Weifeng Tan; Bin Yi; Xiangji Luo; Yong Yu; Xiaoqing Jiang
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

2.  De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data.

Authors:  Boyoung Park; Junghyun Yoon; Dongho Choi; Han Joon Kim; Yun Kyung Jung; Oh Jung Kwon; Kyeong Geun Lee
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.